BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+21.94%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.74B
AUM Growth
+$2.74B
Cap. Flow
+$297M
Cap. Flow %
10.84%
Top 10 Hldgs %
49.25%
Holding
82
New
4
Increased
18
Reduced
6
Closed
10

Top Buys

1
PTGX icon
Protagonist Therapeutics
PTGX
$86.8M
2
GLPG icon
Galapagos
GLPG
$79.8M
3
IONS icon
Ionis Pharmaceuticals
IONS
$51.4M
4
GPCR icon
Structure Therapeutics
GPCR
$41.6M
5
RVMD icon
Revolution Medicines
RVMD
$36.8M

Top Sells

1
RCUS icon
Arcus Biosciences
RCUS
$47.6M
2
CGEM icon
Cullinan Oncology
CGEM
$44.1M
3
VRDN icon
Viridian Therapeutics
VRDN
$27.2M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$21.2M
5
ANNX icon
Annexon
ANNX
$19.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNTA
26
Centessa Pharmaceuticals
CNTA
$2.13B
$36.3M 1.33%
9,423,215
+2,528,870
+37% +$9.74M
IDYA icon
27
IDEAYA Biosciences
IDYA
$2.26B
$33.7M 1.23%
2,455,089
+250,000
+11% +$3.43M
CGEM icon
28
Cullinan Oncology
CGEM
$456M
$32.7M 1.2%
3,196,701
-4,312,358
-57% -$44.1M
RAIN
29
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$30.8M 1.13%
3,526,729
– –
ETNB icon
30
89bio
ETNB
$1.37B
$28.1M 1.03%
+1,846,154
New +$28.1M
ACRS icon
31
Aclaris Therapeutics
ACRS
$223M
$27.2M 0.99%
3,360,941
+84,398
+3% +$683K
ALLK
32
DELISTED
Allakos
ALLK
$27M 0.99%
6,060,247
+1,053,326
+21% +$4.69M
OLMA icon
33
Olema Pharmaceuticals
OLMA
$432M
$26.4M 0.97%
7,611,503
– –
EPIX icon
34
ESSA Pharma
EPIX
$11.2M
$26M 0.95%
8,748,629
– –
ITOS
35
DELISTED
iTeos Therapeutics
ITOS
$24.6M 0.9%
1,810,835
– –
NAMS icon
36
NewAmsterdam Pharma
NAMS
$2.8B
$20.5M 0.75%
1,521,948
– –
JANX icon
37
Janux Therapeutics
JANX
$1.38B
$19.2M 0.7%
1,585,677
+115,343
+8% +$1.4M
THRD
38
DELISTED
Third Harmonic Bio
THRD
$18M 0.66%
4,365,933
– –
CALT
39
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$18M 0.66%
750,000
– –
JSPR icon
40
Jasper Therapeutics
JSPR
$44.2M
$17.9M 0.66%
+9,900,000
New +$17.9M
VIGL
41
DELISTED
Vigil Neuroscience
VIGL
$17.8M 0.65%
1,813,633
– –
OVID icon
42
Ovid Therapeutics
OVID
$94.6M
$17.7M 0.65%
6,851,051
– –
ACIU icon
43
AC Immune
ACIU
$227M
$17.4M 0.64%
7,428,379
– –
STRO icon
44
Sutro Biopharma
STRO
$85.6M
$15.5M 0.57%
3,347,946
– –
ANTX icon
45
AN2 Therapeutics
ANTX
$35.3M
$15.4M 0.56%
1,563,963
– –
CBIO
46
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$12M 0.44%
9,544,262
– –
IMA
47
ImageneBio, Inc. Common Stock
IMA
$153M
$10.9M 0.4%
3,169,164
+666,093
+27% +$2.3M
CTMX icon
48
CytomX Therapeutics
CTMX
$350M
$9.96M 0.36%
6,595,801
– –
ARAV
49
DELISTED
Aravive, Inc. Common Stock
ARAV
$9.57M 0.35%
4,784,214
– –
VERV
50
DELISTED
Verve Therapeutics
VERV
$9.37M 0.34%
650,000
– –
1
2
3 4